ProteinInsight AI
Sign in
Structure-based drug discovery, end to end

Turn protein structure into faster discovery decisions.

Structure, docking, ADMET, PK/PD and safety in one research-grade workspace — taking your team from raw sequence to sourced evidence in minutes, not weeks.

Research use only. No sign-up required to explore the demo.

Three-dimensional protein structure with a ligand bound inside its binding pocket
DOCKING SCORE
−9.4kcal/mol
PK EXPOSURE

Wired into the data sources scientists already trust

UniProtRCSB PDBAlphaFoldESM AtlasChEMBLopenFDA
12
Drug-development stages unified — target discovery to post-market
6+
Public data sources, synced on demand and cited in every result
4
Candidate modalities: small molecule, antibody, peptide and RNA
100%
Research-use-only, with reproducible and fully sourced evidence
Live demo · no sign-up

Explore a real blood-cancer pipeline, instantly

Loading the demo programs…

Explore opens a read-only demo. Create editable sandbox spins up a private, throwaway copy you can edit and run analyses in (auto-expires in 24h). Research use only — not for clinical decision-making.

From sequence to sourced report in three steps

No installs, no pipelines to wire up. Load a target and start discovering.

1

Import your target & protein

Load a protein by UniProt ID, AlphaFold ID, or FASTA sequence and inspect it in 3D instantly.

2

Run the analyses

Docking, ADMET, PK/PD, response simulation and safety signals — run them side by side and rank candidates with calibrated confidence.

3

Generate an evidence report

Produce a restrained, research-use AI report with sources, assumptions and limitations, and share it with your team.

One workspace for every structure-based workflow

WebGL protein viewer
WebGL protein viewer

Rotate and zoom the 3D structure; colour by chain, ligand, binding pocket or pLDDT confidence, and hand a residue straight to docking.

Ligand docking lab
Ligand docking lab

Configure grid boxes and parameters, dock ligand poses, and review interaction maps ranked by binding score and confidence.

ADMET risk analysis
ADMET risk analysis

Estimate absorption, metabolism, toxicity and drug-likeness risk as low / medium / high signals, with rule-based evidence (Lipinski, PAINS…).

PK/PD simulation
PK/PD simulation

Simulate concentration–time curves and compute exposure metrics (AUC, Cmax) to compare dosing scenarios.

Response simulation
Response simulation

Simulate computational response possibility across virtual cohorts with Emax/Hill models to explore a candidate’s response profile.

Safety signal review
Safety signal review

Aggregate openFDA FAERS adverse-event data to review safety signals for research interpretation.

Purpose-built for the entire drug-development journey

Target discovery to post-market — twelve stages in one coherent workspace, not generic project tooling.

01Disease & Target02Candidate Discovery03Optimization04Preclinical05IND06Phase 107Phase 208Phase 309NDA / BLA10CMC / GMP11Launch12Post-market

Protein structure viewer

Inspect chains, ligands, pockets and domains in a dark WebGL workspace; send a residue straight to a docking grid.

Ligand docking lab

Configure grid boxes and parameters, rank poses, and review interaction maps with confidence scoring.

ADMET & safety risk

Estimate absorption, metabolism, toxicity and drug-likeness risk with calibrated low / medium / high signals.

PK/PD response simulation

Simulate concentration–time curves and computational response possibility across virtual cohorts.

AI research report

Generate evidence-backed, restrained research reports with sources, assumptions and limitations.

Connected data sources

UniProtKB, RCSB PDB, AlphaFold, ESM Atlas and Biohub Fold — synced on demand, cached selectively.

Trust isn't a feature — it's the foundation

Rigor, reproducibility and isolation come as standard.

Research use only

Every prediction-bearing screen carries the research-use disclaimer — never for clinical diagnosis, prescription, or treatment.

Reproducible evidence

Every result is tagged with its source, computation type and confidence, so findings can be verified — not taken on faith.

Multi-tenant isolation

Data is scoped per organization with role-based access control and audit logging on sensitive actions.

Your next discovery starts here

Jump into the live demo instantly — no sign-up — or spin up your own workspace and run real analyses in minutes.